Evidence map›Paper›PMID 38702303›Full record

ArticleNPJ primary care respiratory medicine2024

Measuring burden of disease in both asthma and COPD by merging the ACQ and CCQ: less is more?

Liz J A Cuperus, Cathelijne M van Zelst, Huib A M Kerstjens, Rudi W Hendriks, Maureen P M H Rutten-van Molken, Jacqueline B Muilwijk-Kroes, Gert-Jan Braunstahl, Johannes C C M In 't Veen

Abstract read
In one paragraph

Article in NPJ primary care respiratory medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liz J A Cuperus *Pulmonology Department, Franciscus Gasthuis and Vlietland, Rotterdam, the Netherlands. l.cuperus@franciscus.nl.ORCID 0009-0009-6656-1015
Cathelijne M van Zelst *Pulmonology Department, Franciscus Gasthuis and Vlietland, Rotterdam, the Netherlands.
Huib A M KerstjensPulmonology Department, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.ORCID 0000-0001-7705-7927
Rudi W HendriksPulmonology Department, Erasmus Medical Center, Rotterdam, the Netherlands.
Maureen P M H Rutten-van MolkenErasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands.
Jacqueline B Muilwijk-KroesStar-Shl, Diagnostic Center Primary Care, Rotterdam, the Netherlands.
Gert-Jan BraunstahlPulmonology Department, Franciscus Gasthuis and Vlietland, Rotterdam, the Netherlands.ORCID 0000-0001-7671-3742
Johannes C C M In 't VeenPulmonology Department, Franciscus Gasthuis and Vlietland, Rotterdam, the Netherlands.

Funding

Chiesi Pharmaceuticals | Chiesi Foundation unrestricted grant
6 · The paper itself

Abstract

Symptoms of asthma and COPD often overlap, and both diseases can co-exist in one patient. The asthma control questionnaire (ACQ) and clinical COPD questionnaire (CCQ) were developed to assess disease burden in respectively asthma or COPD. This study explores the possibility of creating a new questionnaire to assess disease burden in all obstructive lung diseases by integrating and reducing questions of the ACQ and CCQ. Data of patients with asthma, COPD and asthma-COPD overlap (ACO) were collected from a primary and secondary care center. Patients completed ACQ and CCQ on the same day. Linear regression tested correlations. Principal Component Analysis (PCA) was used for item reduction. The secondary cohort with asthma and COPD patients was used for initial question selection (development cohort). These results were reproduced in the primary care cohort and secondary cohort of patients with ACO. The development cohort comprised 252 patients with asthma and 96 with COPD. Correlation between ACQ and CCQ in asthma was R = 0.82, and in COPD R = 0.83. PCA determined a selection of 9 questions. Reproduction in primary care data (asthma n = 1110, COPD n = 1041, ACO = 355) and secondary care data of ACO patients (n = 53) resulted in similar correlations and PCA-derived selection of questions. In conclusion, PCA determined a selection of nine questions of the ACQ and CCQ: working title 'the Obstructive Lung Disease Questionnaire'. These results suggest that this pragmatic set of questions might be sufficient to assess disease burden in obstructive lung disease in both primary as secondary care.

Indexed as

AsthmaCost of IllnessPulmonary Disease, Chronic ObstructiveAdultAgedFemaleHumansMaleMiddle AgedPrimary Health CareSurveys and Questionnaires

Identifiers

PMID38702303
PMCPMC11068875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.